oral glp-1 tablets BREAKING: The FDA has approved the first pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill The first ever FDA-approved GLP-1

[DOI] [PMC free article] [PubMed] [Google Scholar] [46].Bansal MB, Patton H, Morgan TR, Carr RM, Dranoff JA, Allen AM

Indeed, continuous exenatide exposure once weekly elicited a greater response than did short-acting exenatide, improving glycemic and lipids controls and lipoprotein metabolism, and decreasing systemic inflammation

Yes, SGLT2 inhibitors should be temporarily discontinued 3 days before major surgical procedures requiring fasting and during acute illness, particularly if experiencing reduced food intake, dehydration, or persistent vomiting

Additional information Publishers Note

This finding was further supported by lower area under the curve (AUC) values in the HTH group than in the control group (Supplementary Fig